Marinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in bu
EQS-News: Marinomed Biotech AG / Key word(s): Quarter ResultsMarinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in business development 21.11.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed Biotech AG: Stable revenues in...